A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

Completed

Conditions studied: Eczema, Atopic Dermatitis

In brief

The purpose of this study is to determine if CLn BodyWash, a novel new gel cleanser formulated with surfactants and preserved with sodium hypochlorite, is effective at decreasing severity, body surface area and itching for patients with Atopic Dermatitis, or eczema.

Key facts

Study ID

NCT01714245

Run by

TopMD Skin Care, Inc.

People needed

50

Starts

2012-11-01

Expected to finish

2013-12-01

Last updated by the study team

2019-09-25

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 6 months to 18 years
• moderate to severe Atopic Dermatitis
• positive staphylococcus aureus skin culture

You may not qualify if…

• active clinical infection
• on antibiotics in the last 4 weeks
• on immunosuppression drug in the last 4 weeks
• using bleach bath in the last 2 weeks
• able to maintain current regimen

Where it is running

• Northwestern University, Department of Dermatology — Chicago, Illinois, United States
• University of Texas Medical School - Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.